We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type


Firm name


586 results found


Allen & Overy LLP | Germany | 26 Nov 2018

New legislative proposals in Germany to encourage the use of biosimilars

The German Federal Ministry of Health recently released draft legislation on pharmaceutical drug safety - “Gesetz für mehr Sicherheit in der


Bass, Berry & Sims PLC | USA | 29 Aug 2018

TCPA Exemptions for Healthcare Companies

As healthcare companies increasingly rely on mobile delivery platforms and other technologies to communicate with patients about appointments, billing


Reed Smith LLP | USA | 2 Oct 2017

Fraud on the FDA? If Not Preempted, It Is Trumpery

With Bexis having originally conceived the preemption argument that became Buckman Co. v. Plaintiffs Legal Committee, 531 U.S. 341 (2001), we are


Cooley LLP | USA | 18 Sep 2017

California Governor Considers Drug Price Reporting Bill and Ban on Discounts and Rebates for Branded Pharmaceutical Products

The California State Legislature sent two new pharmaceutical pricing measures, S.B. 17 and A.B. 265, to Governor Jerry Brown on September 13th. S.B


Manatt Phelps & Phillips LLP | USA | 25 Apr 2017

Deceptive Claims in Healthcare: Takeaways From the ULIC Settlement

To the wealth of issues confronting the insurance industry with the new Trump Administration, we can add the old and established concerns about


Manatt Phelps & Phillips LLP | USA | 23 Jan 2017

“Connecting Medicaid Beneficiaries to Social Supports”: Questions Answered

On December 7, Manatt Health and the Anthem Public Policy Institute co-hosted a new webinar examining the growing role of Medicaid managed care in


Cozen O'Connor | USA | 5 Jan 2017

The State AG Report Weekly Update January 5, 2017

Consumer Financial Protection Bureau CFPB Settles with Credit Reporting Companies for Alleged Deceptive Marketing Practices The Consumer Financial


Carlton Fields | USA | 30 Jun 2016

Facebook and HIPAA: Strange Bedfellows

As a social media user, you may have experienced Facebook’s targeted advertising. Mere moments after searching for a specific item on Google or


McDermott Will & Emery | USA | 25 May 2016

CMS’s Final Medicaid Rule Tweaks the Proposed Rules Related to Marketing, Physician Incentive Arrangements and Long-term Care

This article is the second in a series that takes an in-depth look at the new federal Medicaid managed care final rule and its effect on Medicaid


WongPartnership LLP | Singapore | 17 Aug 2015

Market Conduct Rules for Marketing and Distribution Arrangements of Financial Institutions at Retailers and Public Places

The Monetary Authority of Singapore (“MAS”) has issued a Consultation Paper on the proposed Market Conduct Rules for Marketing and Distribution

Previous page 1 2 3 ...